Page 79 - Proceeding of Plenary Abstract of Parallel Symposim
P. 79

Parameter Hematologic as a Diagnosis and Prognosis in Covid-19


           Wulandewi Marhaeni
           Department of Child Health, Faculty of Medicine, Universitas Lambung Mangkurat/Ulin General Hospital, Banjarmasin, South Borneo, Indonesia

           Abstract
           Background  On September 14, 2021, the total cumulative number of Covid-19 cases in Indonesia
           was 4,174,216 cases and 139,415 deaths. So far, data  In Indonesia suggests that children under the age
           of 18 years represent about 12.8% of reported cases.  To date, most children with SARS-CoV-2 infection
           have been asymptomatic  or had mild  Covid-19 symptoms,  but some  children have  had severe illnesses.
           Timely identification of virus carriers is vital not only to prevent their spread but also to more efficiently
           control disease progression. A diverse of abnormal laboratory parameters including hematological,
           inflammatory as well as immunological markers thought to be raised throughout the Covid-19 outbreak.
           Objective To determine the hematological parameters in the diagnosis and prognosis of Covid-19 patients.
           Results Hematological parameters directly reflect the damage of SARS-CoV-2 to human blood cells, which
           can better assess the severity and prognosis of patients infected with Covid-19. The main routine tests for
           Covid-19 patients include complete blood count (CBC), assays investigating coagulation and fibrinolysis
           cascades (PT, APTT, and D-dimers), and inflammation-related parameters (ESR, CRP, ferritin, and
           procalcitonin). Hemocytopenia was common, including lymphopenia, leukopenia, and thrombocytopenia,
           anemia, and increase the neutrophil-to-lymphocyte ratio (NLR), The incidence of lymphopenia in children is
           not as much as in adults. The coagulation profile revealed an obvious elevation of fibrinogen, D-dimer, level
           of prothrombin time (PT),  and partial thromboplastin time (APTT). The inflammation-related parameters
           are highly elevated in acute phases.  In some Covid-19 patients thrombocytopenia and increased PT together
           with prolonged APTT and elevated D-dimers further support the occurrence of coagulopathy that is common
           in severe patients. Conclusion  In Covid- 19  hemocytopenia was common, the occurrence of coagulopathy
           is related to disease progression.

           Keywords: Covid-19, hematologic parameter, coagulopathy, Neutrophil-to-lymphocyte ratio






































          64                                                                      Abstract
   74   75   76   77   78   79   80   81   82   83   84